WHO backs weight-loss drugs for obesity and urges change in mindset
Published on: Sept. 15, 2025, 8:17 p.m. | Source: Devdiscourse
The World Health Organization will recommend using weight-loss drugs to treat obesity in adults, according to draft guidance from the agency that urged countries to take the condition seriously as a chronic disease. The WHO’s expert committee concluded that the popular GLP-1 drugs, first developed by Novo Nordisk and Eli Lilly , are part of the solution for the long-term treatment of obesity for patients with a body mass index (BMI) of 30 or above, alongside counselling on lifestyle and behaviour changes.
